Patents by Inventor Erin E. Jansen

Erin E. Jansen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of preparing pharmaceutical solid state forms
    Patent number: 9314471
    Abstract: The invention provides and describes solid state 17?-ethynyl-5?-androstane-3?,17?-diol including amorphous and crystalline forms and specific polymorphic forms thereof. Anhydrates and solvates of 17?-ethynyl-5?-androstane-3?,17?-diol include Form III anhydrate and Form I solvate. The invention further relates to solid and suspension formulations containing 17?-ethynyl-5?-androstane-3?,17?-diol in a described solid state form and use of the formulations to treat cancers or precancers such as prostate cancer or breast cancer in subjects or human patients. The invention also relates to methods to make liquid formulations from solid state forms of 17?-ethynyl-5?-androstane-3?,17?-diol and uses of such formulations in treating the described conditions.
    Type: Grant
    Filed: June 17, 2013
    Date of Patent: April 19, 2016
    Assignee: NEURMEDIX, INC.
    Inventors: Steven K. White, Erin E. Jansen, Keith Lorimer, Brenton Skylar Wolfe
  • METHODS OF PREPARING PHARMACEUTICAL SOLID STATE FORMS
    Publication number: 20130345455
    Abstract: The invention provides and describes solid state 17?-ethynyl-5?-androstane-3?,17?-diol including amorphous and crystalline forms and specific polymorphic forms thereof. Anhydrates and solvates of 17?-ethynyl-5?-androstane-3?,17?-diol include Form III anhydrate and Form I solvate. The invention further relates to solid and suspension formulations containing 17?-ethynyl-5?-androstane-3?,17?-diol in a described solid state form and use of the formulations to treat cancers or precancers such as prostate cancer or breast cancer in subjects or human patients. The invention also relates to methods to make liquid formulations from solid state forms of 17?-ethynyl-5?-androstane-3?,17?-diol and uses of such formulations in treating the described conditions.
    Type: Application
    Filed: June 17, 2013
    Publication date: December 26, 2013
    Inventors: Steven K. White, Erin E. Jansen, Keith Lorimer, Brenton Skylar Wolfe
  • PHARMACEUTICAL SOLID STATE FORMS-2
    Publication number: 20130345184
    Abstract: The invention provides and describes solid state 17?-ethynyl-5?-androstane-3?,17?-diol including amorphous and crystalline forms and specific polymorphic forms thereof. Anhydrates and solvates of 17?-ethynyl-5?-androstane-3?,17?-diol include Form III anhydrate and Form I solvate. The invention further relates to solid and suspension formulations containing 17?-ethynyl-5?-androstane-3?,17?-diol in a described solid state form and use of the formulations to treat cancers or precancers such as prostate cancer or breast cancer in subjects or human patients. The invention also relates to methods to make liquid formulations from solid state forms of 17?-ethynyl-5?-androstane-3?,17?-diol and uses of such formulations in treating the described conditions.
    Type: Application
    Filed: June 17, 2013
    Publication date: December 26, 2013
    Inventors: Steven K. White, Erin E. Jansen, Keith Lorimer, Brenton Skylar Wolfe
  • STEROID TETROL SOLID STATE FORMS - 2
    Publication number: 20120252774
    Abstract: The invention relates to solid state forms of androst-5-ene-3?,7?,16?,17?-tetrol, formulations containing or prepared from such solid state forms and use of these materials for modulating unwanted inflammation including acute and chronic non-productive inflammation. The formulations can be used to prevent, treat or slow the progression of conditions related to autoimmunity and metabolic disorders such as arthritis, multiple sclerosis, ulcerative colitis, Type 1 diabetes and Type 2 diabetes.
    Type: Application
    Filed: December 16, 2011
    Publication date: October 4, 2012
    Inventors: Steven K. White, Erin E. Jansen
  • STEROID TETROL SOLID STATE FORMS
    Publication number: 20120220560
    Abstract: The invention relates to solid state forms of androst-5-ene-3?,7?,16?,17?-tetrol, formulations containing or prepared from such solid state forms and use of these materials for modulating unwanted inflammation including acute and chronic non-productive inflammation. The formulations can be used to prevent, treat or slow the progression of conditions related to autoimmunity and metabolic disorders such as arthritis, multiple sclerosis, ulcerative colitis, Type 1 diabetes and Type 2 diabetes.
    Type: Application
    Filed: December 16, 2011
    Publication date: August 30, 2012
    Inventors: Steven K. White, Erin E. Jansen